Trust Company of Vermont’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212K | Buy |
+4,967
| New | +$222K | 0.01% | 364 |
|
|
2025
Q4 | $250K | Hold |
5,167
| – | – | 0.01% | 325 |
|
|
2025
Q3 | $244K | Hold |
5,167
| – | – | 0.01% | 333 |
|
|
2025
Q2 | $250K | Hold |
5,167
| – | – | 0.01% | 315 |
|
|
2025
Q1 | $287K | Buy |
5,167
+500
| +11% | +$27.1K | 0.01% | 298 |
|
|
2024
Q4 | $225K | Hold |
4,667
| – | – | 0.01% | 333 |
|
|
2024
Q3 | $269K | Hold |
4,667
| – | – | 0.01% | 298 |
|
|
2024
Q2 | $226K | Hold |
4,667
| – | – | 0.01% | 302 |
|
|
2024
Q1 | $227K | Sell |
4,667
-195
| -4% | -$9.52K | 0.01% | 294 |
|
|
2023
Q4 | $242K | Buy |
4,862
+26
| +0.5% | +$1.27K | 0.02% | 269 |
|
|
2023
Q3 | $259K | Sell |
4,836
-200
| -4% | -$10.7K | 0.02% | 271 |
|
|
2023
Q2 | $271K | Hold |
5,036
| – | – | 0.02% | 279 |
|
|
2023
Q1 | $274K | Sell |
5,036
-310
| -6% | -$15.1K | 0.02% | 276 |
|
|
2022
Q4 | $259K | Sell |
5,346
-350
| -6% | -$15.4K | 0.02% | 272 |
|
|
2022
Q3 | $217K | Sell |
5,696
-250
| -4% | -$11.1K | 0.02% | 289 |
|
|
2022
Q2 | $297K | Sell |
5,946
-100
| -2% | -$5.31K | 0.02% | 256 |
|
|
2022
Q1 | $310K | Sell |
6,046
-385
| -6% | -$19.9K | 0.02% | 259 |
|
|
2021
Q4 | $322K | Hold |
6,431
| – | – | 0.02% | 274 |
|
|
2021
Q3 | $310K | Sell |
6,431
-1,149
| -15% | -$58.4K | 0.02% | 263 |
|
|
2021
Q2 | $399K | Sell |
7,580
-243
| -3% | -$12.7K | 0.03% | 243 |
|
|
2021
Q1 | $387K | Sell |
7,823
-350
| -4% | -$16.8K | 0.03% | 238 |
|
|
2020
Q4 | $397K | Sell |
8,173
-400
| -5% | -$19.7K | 0.03% | 226 |
|
|
2020
Q3 | $431K | Buy |
8,573
+250
| +3% | +$12.9K | 0.04% | 208 |
|
|
2020
Q2 | $425K | Sell |
8,323
-892
| -10% | -$43.4K | 0.04% | 205 |
|
|
2020
Q1 | $403K | Sell |
9,215
-664
| -7% | -$31.8K | 0.04% | 214 |
|
|
2019
Q4 | $496K | Sell |
9,879
-109
| -1% | -$5.11K | 0.04% | 226 |
|
|
2019
Q3 | $463K | Buy |
9,988
+350
| +4% | +$15.1K | 0.04% | 231 |
|
|
2019
Q2 | $417K | Sell |
9,638
-875
| -8% | -$37.2K | 0.03% | 239 |
|
|
2019
Q1 | $465K | Sell |
10,513
-21
| -0.2% | -$900 | 0.04% | 226 |
|
|
2018
Q4 | $457K | Hold |
10,534
| – | – | 0.04% | 219 |
|
|
2018
Q3 | $471K | Sell |
10,534
-19
| -0.2% | -$812 | 0.04% | 228 |
|
|
2018
Q2 | $422K | Buy |
10,553
+308
| +3% | +$12.1K | 0.04% | 235 |
|
|
2018
Q1 | $410K | Sell |
10,245
-1,144
| -10% | -$47.6K | 0.04% | 235 |
|
|
2017
Q4 | $490K | Sell |
11,389
-800
| -7% | -$36.9K | 0.05% | 224 |
|
|
2017
Q3 | $607K | Sell |
12,189
-973
| -7% | -$47.1K | 0.06% | 203 |
|
|
2017
Q2 | $630K | Sell |
13,162
-70
| -0.5% | -$3.35K | 0.06% | 204 |
|
|
2017
Q1 | $599K | Sell |
13,232
-222
| -2% | -$9.42K | 0.06% | 197 |
|
|
2016
Q4 | $544K | Buy |
13,454
+8,954
| +199% | +$353K | 0.06% | 202 |
|
|
2016
Q3 | $172K | Sell |
4,500
-6,050
| -57% | -$243K | 0.02% | 288 |
|
|
2016
Q2 | $442K | Hold |
10,550
| – | – | 0.06% | 190 |
|
|
2016
Q1 | $423K | Hold |
10,550
| – | – | 0.06% | 185 |
|
|
2015
Q4 | $450K | Sell |
10,550
-100
| -0.9% | -$4.6K | 0.06% | 183 |
|
|
2015
Q3 | $505K | Hold |
10,650
| – | – | 0.08% | 170 |
|
|
2015
Q2 | $527K | Sell |
10,650
-84
| -0.8% | -$4.26K | 0.08% | 171 |
|
|
2015
Q1 | $530K | Buy |
10,734
+7,875
| +275% | +$376K | 0.08% | 168 |
|
|
2014
Q4 | $131K | Sell |
2,859
-1,173
| -29% | -$56.9K | 0.02% | 279 |
|
|
2014
Q3 | $228K | Buy |
4,032
+1,566
| +64% | +$84.1K | 0.03% | 212 |
|
|
2014
Q2 | $131K | Buy |
2,466
+68
| +3% | +$3.61K | 0.02% | 260 |
|
|
2014
Q1 | $125K | Sell |
2,398
-81
| -3% | -$4.1K | 0.02% | 263 |
|
|
2013
Q4 | $133K | Sell |
2,479
-835
| -25% | -$43.1K | 0.02% | 260 |
|
|
2013
Q3 | $168K | Buy |
3,314
+83
| +3% | +$4.22K | 0.03% | 227 |
|
|
2013
Q2 | $167K | Buy |
+3,231
| New | +$172K | 0.03% | 221 |
|
Other funds holding SNY
MIP
EIC
DC
TAM
Trust Company of Vermont's SNY Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in Sanofi (SNY) in Q2 2026: 4,967 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #364 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in SNY as recently as Q4 2025.
Trust Company of Vermont first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $630K in Q2 2017. 404 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Trust Company of Vermont held 4,967 shares of Sanofi worth $212K as of Q2 2026.
- Sanofi was a new Trust Company of Vermont position in Q2 2026.
- Sanofi made up 0.01% of Trust Company of Vermont's portfolio in Q2 2026, its #364 holding.
- Trust Company of Vermont first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's Sanofi position peaked at $630K in Q2 2017.
- 404 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.